113 results on '"Themistoclakis, Sakis"'
Search Results
2. Systematic Review on S-ICD Lead Extraction
3. Stereotactic Arrhythmia Radioablation Treatment of Ventricular Tachycardia: Current Technology and Evolving Indications
4. Therapeutic vs. prophylactic anticoagulation in COVID-19 patients: a systematic review and meta-analysis of real-world studies
5. Takotsubo Syndrome during COVID-19 Pandemic in the Veneto Region, Italy
6. Decline of Admission for Acute Coronary Syndromes and Acute Cardiovascular Conditions during COVID-19 Pandemic in Veneto Region
7. Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options
8. MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial
9. In vivo Lesion Index (LSI) validation in percutaneous radiofrequency catheter ablation
10. OUTCOME OF DIFFERENT ABLATION STRATEGIES IN PERSISTENT AND LONG-STANDING PERSISTENT ATRIAL FIBRILLATION: RESULTS FROM A MULTICENTER RANDOMIZED TRIAL (TANTRA)
11. Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration
12. Clinical Outcomes of Left Atrial Appendage Occlusion in Patients with Previous Intracranial or Gastrointestinal Bleeding: Insights from the Logic (Left Atrial Appendage Occlusion in Patients with Gastrointestinal or Intracranial Bleeding) International Multicenter Registry
13. Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial
14. Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial
15. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
16. Natural History of Arrhythmia After Successful Isolation of Pulmonary Veins, Left Atrial Posterior Wall, and Superior Vena Cava in Patients With Paroxysmal Atrial Fibrillation: A Multi‐Center Experience
17. Transcatheter ablation of the atrioventricular junction in refractory atrial fibrillation: A clinicopathological study
18. Periprocedural and Long-Term Anticoagulation
19. Case 18
20. Case 40
21. Case 22
22. Case 34
23. Case 48
24. Case 16
25. Case 10
26. Case 44
27. Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation
28. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
29. Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region, Italy
30. Predictors of recurrence of atrial fibrillation within the first 3 months after ablation
31. Prophylactic Implantation of Implantable Cardioverter/Defibrillators in Post-Myocardial Infarction Patients
32. Searching for Atrial Fibrillation Poststroke
33. Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
34. New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients
35. Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis
36. Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)
37. Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta‐analysis
38. Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
39. IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL
40. Thromboprophylaxis in Patients with Atrial Fibrillation: A Real Practice Analysis
41. Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
42. Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study)
43. Optimization of coronary sinus lead placement targeted to the longest right-to-left delay in patients undergoing cardiac resynchronization therapy: The Optimal Pacing SITE 2 (OPSITE 2) acute study and protocol
44. Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study
45. Real-practice thromboprophylaxis in atrial fibrillation
46. Early Recurrences of Atrial Tachyarrhythmias After Ablation of Atrial Fibrillation
47. Screening for Atrial Fibrillation
48. ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training
49. Reply
50. Reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.